Cooper Companies | COO - Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Align Technology USD 0 0 2024-12
AtriCure USD 61M 865K 2026-03
Avanos Medical USD 87.3M 3M 2026-03
Bausch Health Companies USD 19.9B 720M 2026-03
Baxter International USD 8.62B 852M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Boston Scientific USD 11.01B 19M 2025-12
Cooper Companies USD 1.86B 17.7M 2026-03
Dentsply International USD 2.01B 9M 2026-03
Dexcom USD 1.3B 54.4M 2026-03
Edwards Lifesciences USD 600M 1.7M 2026-03
Globus Medical USD 436K 9K 2025-12
Haemonetics USD 1.22B 299.58M 2026-03
Inogen USD 0 0 2022-06
Insulet USD 929.5M 1.3M 2026-03
Integra LifeSciences USD 1.83B 29.45M 2026-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.53B 1.91B 2026-03
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 735.16M 1.12M 2026-03
Novartis USD 29.59B 5.35B 2025-12
ResMed USD 404.17M 245K 2026-03
STAAR Surgical USD 42K 42K 2023-12
Steris USD 1.81B 85.6M 2026-03
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 601.77M 291.73M 2026-03
Teleflex USD 2.51B 27.18M 2026-03
Utah Medical Products USD 0 0 2022-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03